Blog
RSS FeedPosted by Michael Wonder on 23 Jun 2026
When big pharma clashes with public policy, people such as Aimee pay the price
23 June 2026 - Mother of two and cancer patient Aimee Glen says the decision by a pharmaceutical giant to remove ...
Posted by Michael Wonder on 23 Jun 2026
Affording the successes of science
20 June 2026 - Australia needs a difficult conversation about the world’s best medicines, what they cost and who should pay. ...
Posted by Michael Wonder on 22 Jun 2026
They’re on the PBS but Xavier still can’t access these cancer drugs
20 June 2026 - The eight-year-old and his family will travel to America next month to pick up medicine that is ...
Posted by Michael Wonder on 22 Jun 2026
Australia’s drug approval system faces reckoning as patients await reform
22 June 2026 - Health Minister Mark Butler has tied long-overdue drug pricing reforms to July negotiations with pharma, leaving Australia’s ...
Posted by Michael Wonder on 20 Jun 2026
Mounjaro rejection explains why our access to cheaper medicines if failing
20 June 2026 - The rejection by one of the world’s biggest pharmaceutical companies of Australia’s proferred bargain over the ...
Posted by Michael Wonder on 20 Jun 2026
Australian patients risk losing lifesaving medicines amid pharmaceutical subsidy crisis
20 June 2026 - Australian patients risk losing access to lifesaving medicines, with the nation “cleaved off” from global drug ...
Posted by Michael Wonder on 19 Jun 2026
Recommendations made by the PBAC – May 2026
19 June 2026 - Recommendations made by the PBAC in May 2026 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 19 Jun 2026
Redesigned PBS website improves search functionality and medicine visibility
18 June 2026 - The Department of Health, Disability and Ageing has launched a redesigned PBS website, featuring enhanced search functionality, ...
Posted by Michael Wonder on 11 Jun 2026
Update from the PBAC (May 2026)
11 June 2026 - The PBAC held a one day intracycle meeting on 8 May 2026. ...
Posted by Michael Wonder on 08 Jun 2026
Eli Lilly savages Australia’s health subsidies in its standoff over weight loss and diabetes drug
7 June 2026 - Pharmaceutical giant Eli Lilly has delivered a scathing critique of Australia’s medicines subsidy process, saying the ...
Posted by Michael Wonder on 04 Jun 2026
AstraZeneca pulls critical breast cancer and endometriosis drug Zoladex from shelves
4 June 2026 - A life-saving breast cancer and endometriosis drug will be pulled from Australian shelves by a major ...
Posted by Michael Wonder on 03 Jun 2026
Global tensions with US President Donald Trump could threaten affordable medicines in Australia
2 June 2026 - Australia’s access to affordable medicines could be under threat from global tensions, with one woman forced to ...
Posted by Michael Wonder on 03 Jun 2026
Cheaper medicines for people fighting leukaemia and migraines
3 June 2026 - The Albanese Government is continuing to deliver cheaper medicines with Australians with types of leukaemia and ...
Posted by Michael Wonder on 01 Jun 2026
Expanded listing to save leukaemia patients $35.5 million a year
1 June 2026 - Eligible patients with leukaemia will have access to $25 scripts for two new treatments following their ...
Posted by Michael Wonder on 24 May 2026
Changes to PBS wholesale mark-up fees from 1 July 2026
22 May 2026 - A fact sheet on the new wholesale mark-up structure for PBS medicines supplied through community pharmacies is ...